29
/fr/
fr
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Créer
Public Timelines
Bibliothèque
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Télécharger
Export
Créer une copie
Intégrer dans le site Web
Éditer
Les affichages 357
0
0
Cancer Genomics Timeline
A été creé
鹰崖
⟶ mise à jour avec succès 30 nov. 2017 ⟶
List of edits
Commentaires
Les événements
dbSNP established (Aug)
The Hallmarks of Cancer (Jan)
Draft human genome finished (Feb)
HapMap project started (Oct)
Human genome (build 34) finshed (Apr)
COSMIC initiated (May)
TCGA pilot project announced (Dec)
SOLID II sequencer introduced (Jan)
Tumor Sequencing Project (TSP) initiated (Sep)
JD Watson sequenced (Apr)
Human genome (GRC37) released (hg19) (Feb)
Aglient SureSelect launched (Feb)
Illumina HiSeq2000 introduced (Jan)
Hallmarks of Cancer: The Next Generation (Mar)
ENCODE project phase II completed (Sep)
Human genome (GRC38) released (hg38) (Dec)
Precision medicine initiative (Jan)
Cancer moonshot (Jan)
FDA approval: first gene therapy (Aug)
ENCODE project started (Oct)
454 GS-20 sequencer launched (Dec)
Illumina GA sequencer introduced (Dec)
Human genome (build 36) finished (hg18) (Mar)
ICGC initiated (Nov)
CRC and breast 11 WES completed (Nov)
NimbleGen capture technology published (Nov)
AML WGS published (Nov)
TCGA initiated (Dec)
Tumor heterogeneity measured at genome level (Nov)
Tumor evolution inferred by single cell sequencing (Apr)
315 OSCC cases analyzed by NGS (Jun)
1000 Genomes project phase I completed (Nov)
1000 Genomes project completed (Phase III) (Oct)
AMP & CAP published guideline to address NGS workflows (Dec)
FDA authorizes MSK-IMPACT test for analyzing patient tumors (Nov)
The FDA approves pembrolizumab (PD1)